Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap11.9B
Enterprise Value11.61B
P/E Ratio12.15
PEG Ratio0.84
Price/Sales Ratio4.71
Price/Book Ratio5.9
Enterprise/Revenue4.56
Enterprise/EBITDA12.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.29
Operating Margin0.33
AD

Management Effectiveness

Return On Assets0.29
Return On Equity0.39

Income Statement

Revenue2.47B
Revenue/Share7.59
Gross Profit2.01B
EBITDA917.4M
Net Income695.86M
Diluted EPS2.83

Balance Sheet

Total Cash466.25M
Total Cash/Share1.3
Total Debt71.98M
Total Debt/Equity0.03
Current Ratio1.95
Book Value Per Share6.05

Price History

52-Week Change-28.35
52-Week High59.07
52-Week Low35.1
Moving Average 50 Days40.46
Moving Average 200 Days44.95

Statistics

Average Volume8.36M
Shares Outstanding357.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.48
Trailing Annual Dividend Yield4.15
Payout Ratio0.31
Last Split Factor29:20
Last Split DateMay 22, 2026
AD